HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
New artificial intelligence models have unpredictable consumption-based costs, says Rhett Alden, Elsevier's CTO of health markets. But "all you can eat models" and inclusive pricing can avoid the need for clinicians to meter tool use.
The underlying challenge is how to fund an industry that's very important but is also perpetually on the brink of bankruptcy, says Kunal Sarda, CEO of Arya Health.
Dr. Deepti Pandita, CMIO and VP of clinical Informatics at UCI Health, says healthcare organizations may not always know where every AI tool exists, making system-wide AI awareness and governance essential.
Amy Chacko, IT portfolio manager at Hackensack Meridian Health, says the HIMSS chapter members she's spoken with are implementing AI slowly and carefully due to concerns about patient safety and achieving strategic goals.
Nicole Ramage, HIMSS' senior global market insights manager, says her department's focus is expanding to help healthcare leaders better understand AI adoption, market trends and regional differences across North America, EMEA and APAC.
Baxter Lee, president of Clearwater, says building organizational resilience in an AI-driven threat landscape is a must despite critical national coordination efforts to patch healthcare vulnerabilities swiftly.
Pothik Chatterjee says Houston Methodist & Rice University's Digital Health Institute combines AI algorithms with data from disparate sources including clinical images to uncover patterns that can inform patient care.
The University of Maryland Medical Center's Tiffany Kuebler urges healthcare leaders to begin AI implementation with workflows that are technologically ready for it and that will deliver the most operational value.
Matthew Laskowski, CEO of Toby, discusses the machine learning and biomarker analysis technology behind the company’s urine-based multi-cancer detection test that has received FDA Breakthrough Device designation in the United States.
Intel's Renu Navale says edge AI can be effective for assisting with time-critical clinical tasks and explains how leaders can build hybrid AI strategies that place each workflow where it delivers the greatest value for care.
As AI technology becomes more widely accepted, Anne Snowdon, HIMSS' chief scientific research officer, says healthcare leaders increasingly demand proof that AI tools can solve their specific challenges in measurable ways.
Tara Steele, executive director of the Safe AI for Children Alliance, says new AI apps must be proactively built to shield children from harm, rather than changed after children have been harmed or endangered.